Stock listing

OTC:GALDY Galderma Group AG Stock

US listing (OTC) of Galderma Group AG · home listing SIX Swiss:GALD

Follow Galderma Group AG into a list and get an email when it puts out news.

Share price · OTC:GALDY

$41.94 USD -0.46 (-1.1%)

Close on Oct 19, 2026

Day range
$41.80 – $43.10 USDOct 19, 2026
Volume
90,207 sharesOct 19, 2026
Market cap
$48.90B USDAt the close on Oct 19, 2026 · price × 1.17B shares outstanding
Galderma Group AG logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
SIX Swiss:GALD · Home175.00 CHF+1.30 (+0.7%)385,302174.05175.70173.20173.70Close on Oct 20, 2026
OTC:GDERF$220.25 USD-0.30 (-0.1%)200$220.31$220.31$220.25$220.55Close on Oct 19, 2026
OTC:GALDY$41.94 USD-0.46 (-1.1%)90,207$43.10$43.10$41.80$42.40Close on Oct 19, 2026
Frankfurt:PY30€36.40 EUR+0.20 (+0.6%)—€36.00€36.40€36.00€36.20Close on Oct 20, 2026
Ticker
OTC:GALDY
Asset type
Stock
Exchange
OTC
Currency
USD

What changed lately

Calls

Replays

  • Galderma Group (SIX Swiss: GALD) Q2 2026 Earnings Call

    Thu, Jul 23, 2026 · 7:00 AM ET

    Watch Transcript

  • Galderma Group (SIX Swiss: GALD) Q4 2025 Earnings Call

    Thu, Mar 05, 2026 · 8:00 AM ET

    Watch Transcript

  • Galderma Group (SIX Swiss: GALD) Q3 2025 Earnings Call

    Thu, Oct 23, 2025 · 3:30 PM ET

    Watch Transcript

Latest news

30 Years of Restylane®: Reshaping the Aesthetics Field Through Science-Led, Patient-Centric Innovation

Oct 6, 2026

EADV 2026: Galderma to Unveil New Data Advancing Understanding of Skin Diseases, Skin Longevity, and Real-world Patient Experiences

Sep 23, 2026

Galderma Begins Trading in the Swiss Market Index, Joining Switzerland's Leading Blue Chip Companies

Sep 21, 2026

Galderma’s Restylane® Volyme™ Demonstrates High Effectiveness, Satisfaction and a Robust Safety Profile in Chinese Patients With Temple Hollowing

Sep 16, 2026

Galderma opens new U.S. and Latin America headquarters in Miami

Aug 24, 2026

Galderma Receives European Union Approval for Restylane® Shaype™: the First-and-Only Bone-Mimicking Hyaluronic Acid Injectable for Facial Shaping

Aug 11, 2026

Galderma Reports Record First Half 2026 Net Sales of 3.134 Billion USD and 24.6% Year-on-Year Growth at Constant Currency, Raises Net Sales Guidance for the Full Year

Jul 23, 2026

Galderma Launches Alastin® in Japan and Key Markets Across Asia Pacific, Expanding Its Footprint in the Region

Jul 20, 2026

Landmark Global Galderma Survey Shows 9 out of 10 People Are Affected by Skin Quality Concerns

Jul 7, 2026

Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States

Jul 1, 2026

All Galderma Group AG news

Decks

Galderma Group AG on 6ix

News releases
46 in the last 12 months · 68 in all · newest Oct 6, 2026 · oldest 2025
Calls
6 calls with a replay · 6 with a transcript · latest Jul 23, 2026
Decks
11 decks · latest Jul 23, 2026

Where Galderma Group AG is listed

ListingExchangeCountryCurrency
SIX Swiss:GALD · Home listingSIX SwissSwitzerlandCHF
OTC:GDERFOTCUnited StatesUSD
OTC:GALDY · This pageOTCUnited StatesUSD
gettex:PY3gettexGermanyEUR
Milan:1GALDMilanItalyEUR
LS Exchange:A407X6LS ExchangeGermanyEUR
Frankfurt:PY3FrankfurtGermanyEUR
BX Swiss:GALDBX SwissSwitzerlandCHF
VIE:GALDViennaAustriaEUR
Lang & Schwarz:A407X6Lang & SchwarzGermanyEUR
Aquis:GALDZAquisUnited KingdomCHF
Tradegate:PY3TradegateGermanyEUR
BMV:GALDNBMVMexicoMXN
Stuttgart:PY3StuttgartGermanyEUR
Frankfurt:PY30FrankfurtGermanyEUR
BIVA:GALDNBIVAMexicoMXN
Dusseldorf:PY3DusseldorfGermanyEUR
Munich:PY3MunichGermanyEUR
Turquoise:GALDZTurquoiseUnited KingdomCHF

Log in to ask 6ix AI your own questions about Galderma Group AG.